Workshop on Infections after Fracture Fixation (IFF) (Oct 14 - 15, 2019)

Workshop on Infections after Fracture Fixation (IFF) is organized by PRO-IMPLANT Foundation and will be held from Oct 14 - 15, 2019 at Langenbeck-Virchow-Haus, Berlin, Germany.

Target Audience:
Clinicians and life-science researchers with advanced knowledge and interest in implant-associated infections of the following specialties (or enrolled in an educational program):
Trauma, orthopedic or related surgeons dealing with bone and implant-associated infections after fracture
Internal medicine (micro)biology, infectious diseases or related fields dealing with biofilms and antibiotics
Pharmacy, pharmacology or related fields dealing with pharmacokinetics/pharmacodynamics
Ideally a complementary team (pair) from individual institutions should attend the same workshop, i.e. orthopedic/trauma surgeon and microbiologist/infectious diseases specialist.

Goal:
To review, update and advance the theoretical and practical knowledge in diagnosis, treatment  and  prevention of bone and implant-associated infections. At the end of the workshop, participants should be able to generate a rational and efficient management plan based on modern principles.

Topics for discussion:
• Epidemiology, definition and pathogenesis of bone and implantassociated infections after trauma
• Diagnosis: microbiology, histology, imaging
• Surgical and antimicrobial therapy
• Local antimicrobial therapy, drug delivery systems, bone cement, bone
substitutes and bone grafts
• Early postoperative infections: when to revise? What to revise?
• Delayed postoperative infection: concept of septic delayed and nonunion
• Culture-negative infections: How to treat?
• Efficient and cost-effective prevention of infection
• Difficult surgical cases: multiple revisions, compromised soft tissues,
insufficient bone stock, persistent infection
• Therapeutic options for difficult-to-treat and multi-drug resistant
microorganisms
• Typical errors leading to treatment failure
• The importance of animal models to bridge the gap from in vitro to
clinical studies
• Potential future solutions: implant coating, bone regeneration,
bacteriophage therapy, hydrogels